These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34319212)

  • 1. Fracture risk assessment by the FRAX model.
    McCloskey EV; Harvey NC; Johansson H; Lorentzon M; Liu E; Vandenput L; Leslie WD; Kanis JA
    Climacteric; 2022 Feb; 25(1):22-28. PubMed ID: 34319212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of hip fracture in Brazil and the development of a FRAX model.
    Zerbini CA; Szejnfeld VL; Abergaria BH; McCloskey EV; Johansson H; Kanis JA
    Arch Osteoporos; 2015; 10():224. PubMed ID: 26303038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.
    Leslie WD; Lix LM; Langsetmo L; Berger C; Goltzman D; Hanley DA; Adachi JD; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2011 Mar; 22(3):817-27. PubMed ID: 21161509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FRAX Update.
    Kanis JA; Harvey NC; Johansson H; Odén A; Leslie WD; McCloskey EV
    J Clin Densitom; 2017; 20(3):360-367. PubMed ID: 28732576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?
    Leslie WD; Morin SN; Lix LM; Majumdar SR
    Osteoporos Int; 2014 Dec; 25(12):2817-24. PubMed ID: 25092059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidance for the adjustment of FRAX according to the dose of glucocorticoids.
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Osteoporos Int; 2011 Mar; 22(3):809-16. PubMed ID: 21229233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year.
    Kanis JA; Johansson H; Harvey NC; Lorentzon M; Liu E; Vandenput L; Morin S; Leslie WD; McCloskey EV
    Osteoporos Int; 2023 Mar; 34(3):479-487. PubMed ID: 36562788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study.
    Ettinger B; Ensrud KE; Blackwell T; Curtis JR; Lapidus JA; Orwoll ES;
    Osteoporos Int; 2013 Apr; 24(4):1185-93. PubMed ID: 23179575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Methods for Improving Fracture Risk Assessment in Diabetes: The Manitoba BMD Registry.
    Leslie WD; Johansson H; McCloskey EV; Harvey NC; Kanis JA; Hans D
    J Bone Miner Res; 2018 Nov; 33(11):1923-1930. PubMed ID: 29953670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density.
    Klop C; de Vries F; Bijlsma JW; Leufkens HG; Welsing PM
    Ann Rheum Dis; 2016 Dec; 75(12):2095-2100. PubMed ID: 26984006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.
    Vandenput L; Johansson H; McCloskey EV; Liu E; Åkesson KE; Anderson FA; Azagra R; Bager CL; Beaudart C; Bischoff-Ferrari HA; Biver E; Bruyère O; Cauley JA; Center JR; Chapurlat R; Christiansen C; Cooper C; Crandall CJ; Cummings SR; da Silva JAP; Dawson-Hughes B; Diez-Perez A; Dufour AB; Eisman JA; Elders PJM; Ferrari S; Fujita Y; Fujiwara S; Glüer CC; Goldshtein I; Goltzman D; Gudnason V; Hall J; Hans D; Hoff M; Hollick RJ; Huisman M; Iki M; Ish-Shalom S; Jones G; Karlsson MK; Khosla S; Kiel DP; Koh WP; Koromani F; Kotowicz MA; Kröger H; Kwok T; Lamy O; Langhammer A; Larijani B; Lippuner K; Mellström D; Merlijn T; Nordström A; Nordström P; O'Neill TW; Obermayer-Pietsch B; Ohlsson C; Orwoll ES; Pasco JA; Rivadeneira F; Schei B; Schott AM; Shiroma EJ; Siggeirsdottir K; Simonsick EM; Sornay-Rendu E; Sund R; Swart KMA; Szulc P; Tamaki J; Torgerson DJ; van Schoor NM; van Staa TP; Vila J; Wareham NJ; Wright NC; Yoshimura N; Zillikens MC; Zwart M; Harvey NC; Lorentzon M; Leslie WD; Kanis JA
    Osteoporos Int; 2022 Oct; 33(10):2103-2136. PubMed ID: 35639106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longer Duration of Diabetes Strongly Impacts Fracture Risk Assessment: The Manitoba BMD Cohort.
    Majumdar SR; Leslie WD; Lix LM; Morin SN; Johansson H; Oden A; McCloskey EV; Kanis JA
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4489-4496. PubMed ID: 27603908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of major osteoporotic and hip fractures in Australian men using FRAX scores adjusted with trabecular bone score.
    Holloway KL; Mohebbi M; Betson AG; Hans D; Hyde NK; Brennan-Olsen SL; Kotowicz MA; Pasco JA
    Osteoporos Int; 2018 Jan; 29(1):101-108. PubMed ID: 28940052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice.
    Leslie WD; Majumdar SR; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
    Osteoporos Int; 2012 Jan; 23(1):391-7. PubMed ID: 21365460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of hip fracture and the development of FRAX in Ukraine.
    Povoroznyuk VV; Grygorieva NV; Kanis JA; Ev M; Johansson H; Harvey NC; Korzh MO; Strafun SS; Vaida VM; Klymovytsky FV; Vlasenko RO; Forosenko VS
    Arch Osteoporos; 2017 Dec; 12(1):53. PubMed ID: 28567714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.
    Fraser LA; Langsetmo L; Berger C; Ioannidis G; Goltzman D; Adachi JD; Papaioannou A; Josse R; Kovacs CS; Olszynski WP; Towheed T; Hanley DA; Kaiser SM; Prior J; Jamal S; Kreiger N; Brown JP; Johansson H; Oden A; McCloskey E; Kanis JA; Leslie WD;
    Osteoporos Int; 2011 Mar; 22(3):829-37. PubMed ID: 21161508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjusting conventional FRAX estimates of fracture probability according to the number of prior fractures.
    Kanis JA; Johansson H; Harvey NC; Gudnason V; Sigurdsson G; Siggeirsdottir K; Lorentzon M; Liu E; Vandenput L; McCloskey EV
    Osteoporos Int; 2022 Dec; 33(12):2507-2515. PubMed ID: 36161339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women's Health Initiative hormone therapy trials.
    Lorentzon M; Johansson H; Harvey NC; Liu E; Vandenput L; Crandall CJ; Cauley JA; LeBoff MS; McCloskey EV; Kanis JA
    Osteoporos Int; 2022 Nov; 33(11):2297-2305. PubMed ID: 35833956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway.
    Hoff M; Meyer HE; Skurtveit S; Langhammer A; Søgaard AJ; Syversen U; Dhainaut A; Skovlund E; Abrahamsen B; Schei B
    Osteoporos Int; 2017 Oct; 28(10):2935-2944. PubMed ID: 28668994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fracture Risk Assessment Tool (FRAX®) predicts fracture risk in patients with chronic kidney disease.
    Whitlock RH; Leslie WD; Shaw J; Rigatto C; Thorlacius L; Komenda P; Collister D; Kanis JA; Tangri N
    Kidney Int; 2019 Feb; 95(2):447-454. PubMed ID: 30579724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.